1 not yet recruiting. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Not yet recruiting 1 |
Follow 5-12cm to Anal Verge: new trials by email Literature Review of 5-12cm to Anal Verge trials Research Report on 5-12cm to Anal Verge
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Iparomlimab and Tuvonralimab Combined With Chemotherapy and Bevacizumab as Neoadjuvant Therapy for Locally Advanced Rectal Cancer Iparomlimab and Tuvonralimab（QL-1706）combined with Chemotherapy and Bevacizumab - Locally Advanced Rectal Cancer (LARC), 5-12cm to Anal Verge | Not applicable | Not yet recruiting | Zhejiang University | 56 | 2026-09-01 | 2026-09-15 |
Bevacizumab (1) · Drug Therapy (1) · Radiotherapy (1) · Surgical Procedures, Operative (1)